316 related articles for article (PubMed ID: 34051319)
21. Recent Advances in Polymer Microneedles for Drug Transdermal Delivery: Design Strategies and Applications.
Wang R; Jiang G; Aharodnikau UE; Yunusov K; Sun Y; Liu T; Solomevich SO
Macromol Rapid Commun; 2022 Apr; 43(8):e2200037. PubMed ID: 35286762
[TBL] [Abstract][Full Text] [Related]
22. Microneedles: A smart approach and increasing potential for transdermal drug delivery system.
Waghule T; Singhvi G; Dubey SK; Pandey MM; Gupta G; Singh M; Dua K
Biomed Pharmacother; 2019 Jan; 109():1249-1258. PubMed ID: 30551375
[TBL] [Abstract][Full Text] [Related]
23. Leveraging novel innovative thermoresponsive polymers in microneedles for targeted intradermal deposition.
Roussel S; Udabe J; Bin Sabri A; Calderón M; Donnelly R
Int J Pharm; 2024 Mar; 652():123847. PubMed ID: 38266945
[TBL] [Abstract][Full Text] [Related]
24. Nanocomposite-strengthened dissolving microneedles for improved transdermal delivery to human skin.
Yan L; Raphael AP; Zhu X; Wang B; Chen W; Tang T; Deng Y; Sant HJ; Zhu G; Choy KW; Gale BK; Prow TW; Chen X
Adv Healthc Mater; 2014 Apr; 3(4):555-64. PubMed ID: 24173960
[TBL] [Abstract][Full Text] [Related]
25. Multilayered pyramidal dissolving microneedle patches with flexible pedestals for improving effective drug delivery.
Lau S; Fei J; Liu H; Chen W; Liu R
J Control Release; 2017 Nov; 265():113-119. PubMed ID: 27574991
[TBL] [Abstract][Full Text] [Related]
26. Novel dissolving microneedles for enhanced transdermal delivery of levonorgestrel: In vitro and in vivo characterization.
Yao G; Quan G; Lin S; Peng T; Wang Q; Ran H; Chen H; Zhang Q; Wang L; Pan X; Wu C
Int J Pharm; 2017 Dec; 534(1-2):378-386. PubMed ID: 29051119
[TBL] [Abstract][Full Text] [Related]
27. Microneedles: an emerging transdermal drug delivery system.
Bariya SH; Gohel MC; Mehta TA; Sharma OP
J Pharm Pharmacol; 2012 Jan; 64(1):11-29. PubMed ID: 22150668
[TBL] [Abstract][Full Text] [Related]
28. Considerations in the use of microneedles: pain, convenience, anxiety and safety.
Jeong HR; Lee HS; Choi IJ; Park JH
J Drug Target; 2017 Jan; 25(1):29-40. PubMed ID: 27282644
[TBL] [Abstract][Full Text] [Related]
29. Characterization of microneedles and microchannels for enhanced transdermal drug delivery.
Puri A; Nguyen HX; Tijani AO; Banga AK
Ther Deliv; 2021 Jan; 12(1):77-103. PubMed ID: 33410340
[TBL] [Abstract][Full Text] [Related]
30. Unravelling the role of microneedles in drug delivery: Principle, perspectives, and practices.
Babu MR; Vishwas S; Khursheed R; Harish V; Sravani AB; Khan F; Alotaibi B; Binshaya A; Disouza J; Kumbhar PS; Patravale V; Gupta G; Loebenberg R; Arshad MF; Patel A; Patel S; Dua K; Singh SK
Drug Deliv Transl Res; 2024 Jun; 14(6):1393-1431. PubMed ID: 38036849
[TBL] [Abstract][Full Text] [Related]
31. Microneedles for drug delivery: recent advances in materials and geometry for preclinical and clinical studies.
Kang NW; Kim S; Lee JY; Kim KT; Choi Y; Oh Y; Kim J; Kim DD; Park JH
Expert Opin Drug Deliv; 2021 Jul; 18(7):929-947. PubMed ID: 32975144
[TBL] [Abstract][Full Text] [Related]
32. Rapidly separating microneedles for transdermal drug delivery.
Zhu DD; Wang QL; Liu XB; Guo XD
Acta Biomater; 2016 Sep; 41():312-9. PubMed ID: 27265152
[TBL] [Abstract][Full Text] [Related]
33. Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery.
Park JH; Allen MG; Prausnitz MR
J Control Release; 2005 May; 104(1):51-66. PubMed ID: 15866334
[TBL] [Abstract][Full Text] [Related]
34. A highly robust approach to fabricate the mass-customizable mold of sharp-tipped biodegradable polymer microneedles for drug delivery.
Lim H; Ha S; Bae M; Yoon SH
Int J Pharm; 2021 May; 600():120475. PubMed ID: 33737092
[TBL] [Abstract][Full Text] [Related]
35. Two-layered dissolving microneedles for percutaneous delivery of peptide/protein drugs in rats.
Fukushima K; Ise A; Morita H; Hasegawa R; Ito Y; Sugioka N; Takada K
Pharm Res; 2011 Jan; 28(1):7-21. PubMed ID: 20300802
[TBL] [Abstract][Full Text] [Related]
36. [Advances in the applications of dissolving polymer microneedles for delivering drugs in ocular diseases].
Wang SM; Lin S; Nan KH
Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):960-966. PubMed ID: 37936365
[TBL] [Abstract][Full Text] [Related]
37. Formulation and characterisation of dissolving microneedles for the transdermal delivery of therapeutic peptides.
Dillon C; Hughes H; O'Reilly NJ; McLoughlin P
Int J Pharm; 2017 Jun; 526(1-2):125-136. PubMed ID: 28461268
[TBL] [Abstract][Full Text] [Related]
38. IgG-loaded hyaluronan-based dissolving microneedles for intradermal protein delivery.
Mönkäre J; Reza Nejadnik M; Baccouche K; Romeijn S; Jiskoot W; Bouwstra JA
J Control Release; 2015 Nov; 218():53-62. PubMed ID: 26437262
[TBL] [Abstract][Full Text] [Related]
39. Microneedles and transdermal applications.
Sivamani RK; Liepmann D; Maibach HI
Expert Opin Drug Deliv; 2007 Jan; 4(1):19-25. PubMed ID: 17184159
[TBL] [Abstract][Full Text] [Related]
40. Study on the fabrication and characterization of tip-loaded dissolving microneedles for transdermal drug delivery.
Zhuang J; Rao F; Wu D; Huang Y; Xu H; Gao W; Zhang J; Sun J
Eur J Pharm Biopharm; 2020 Dec; 157():66-73. PubMed ID: 33059004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
